James Archie Harrell Jr. - 10 Dec 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Chief Commercial Officer
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
10 Dec 2021
Net transactions value
+$1,716
Form type
4
Filing time
14 Dec 2021, 16:16:21 UTC
Previous filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $1,716 +1,093 +3.1% $1.57 36,766 10 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.